image_alt_text
4

Jay Lieberman, M.D.

AIMBE College of Fellows Class of 2009
For significant and sustained contributions to understanding the biology of arthroplasty implants, and for innovative strategies for bone regeneration using gene therapy and materials science.

Elevated Glucose Levels in Non-Diabetic Patients = Higher PJI Risk?

Via Orthopedics This Week | February 15, 2024

While diabetic total hip arthroplasty (THA) patients are associated with higher levels of periprosthetic joint infection (PJI), does that, therefore, imply that non-diabetic patients with elevated glucose levels are also at higher risk of PJI?

A research team from the University of Southern California (USC) Keck School of Medicine designed a 90,830-patient study to answer that question. Their work, “Higher Blood Glucose Levels on the Day of Surgery Are Associated with an Increased Risk of Periprosthetic Joint Infection After Total Hip Arthroplasty,” appears in the December 21, 2023 edition of The Journal of Bone and Joint Surgery… Continue reading.